Pembrolizumab for Early Triple-Negative Breast Cancer
Pembrolizumab for Early Triple-Negative Breast Cancer
About this item
Full title
Author / Creator
Schmid, Peter , Cortes, Javier , Pusztai, Lajos , McArthur, Heather , Kümmel, Sherko , Bergh, Jonas , Denkert, Carsten , Park, Yeon Hee , Hui, Rina , Harbeck, Nadia , Takahashi, Masato , Foukakis, Theodoros , Fasching, Peter A , Cardoso, Fatima , Untch, Michael , Jia, Liyi , Karantza, Vassiliki , Zhao, Jing , Aktan, Gursel , Dent, Rebecca , O’Shaughnessy, Joyce and KEYNOTE-522 Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
The addition of pembrolizumab to platinum-based neoadjuvant chemotherapy significantly increased the percentage of patients with a pathological complete response among patients with locally advanced triple-negative breast cancer. Side effects of the immunotherapy were added to the usual toxic effects of chemotherapy, but most patients completed pla...
Alternative Titles
Full title
Pembrolizumab for Early Triple-Negative Breast Cancer
Authors, Artists and Contributors
Author / Creator
Cortes, Javier
Pusztai, Lajos
McArthur, Heather
Kümmel, Sherko
Bergh, Jonas
Denkert, Carsten
Park, Yeon Hee
Hui, Rina
Harbeck, Nadia
Takahashi, Masato
Foukakis, Theodoros
Fasching, Peter A
Cardoso, Fatima
Untch, Michael
Jia, Liyi
Karantza, Vassiliki
Zhao, Jing
Aktan, Gursel
Dent, Rebecca
O’Shaughnessy, Joyce
KEYNOTE-522 Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_473184
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_473184
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1910549
